Skip to main content
Article thumbnail
Location of Repository

Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine

By Jason S. Richardson, Michel K. Yao, Kaylie N. Tran, Maria A. Croyle, James E. Strong, Heinz Feldmann and Gary P. Kobinger
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2669164
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). Fields Virology. In: Knipe D, Howley PM, eds (2007) Marburg and Ebola viruses. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins.
    2. (2001). Ebola virus: the search for vaccines and treatments.
    3. (2005). Fruit bats as reservoirs of Ebola virus.
    4. (2005). Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    5. (2003). Ebola virus: from discovery to vaccine.
    6. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management.
    7. (2004). Biology of adenovirus and its use as a vector for gene therapy.
    8. (2005). Innate immune response to adenovirus.
    9. (2000). Development of a preventive vaccine for Ebola virus infection in primates.
    10. (2006). Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
    11. (2003). Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
    12. (2007). In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
    13. (2002). Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.
    14. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector.
    15. (1997). Green mice’ as a source of ubiquitous green cells.
    16. (2006). Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
    17. (1998). A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
    18. Imperiale MJ (2004) Biology of adenovirus and its use as a vector for gene therapy.
    19. (2007). Status and challenges of filovirus vaccines.
    20. (2004). Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.
    21. (2006). Immune protection of nonhuman primates against Ebola virus with single lowdose adenovirus vectors encoding modified GPs.
    22. (1991). The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.
    23. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.
    24. (2006). Post-exposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
    25. (1995). GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.
    26. (1995). Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.
    27. (1999). Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.